Advantage Alpha Capital Partners’s ADMA Biologics ADMA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $798K | Sell |
43,818
-62,257
| -59% | -$1.13M | 0.22% | 92 |
|
|
2025
Q1 | $2.1M | Buy |
106,075
+36,893
| +53% | +$732K | 0.52% | 77 |
|
|
2024
Q4 | $1.19M | Sell |
69,182
-18,209
| -21% | -$312K | 0.28% | 90 |
|
|
2024
Q3 | $1.75M | Sell |
87,391
-66,160
| -43% | -$1.32M | 0.4% | 89 |
|
|
2024
Q2 | $1.72M | Sell |
153,551
-30,915
| -17% | -$346K | 0.37% | 82 |
|
|
2024
Q1 | $1.22M | Buy |
+184,466
| New | +$1.22M | 0.23% | 91 |
|